These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8201630)

  • 41. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Women in drug abuse treatment programs: factors that influence retention at very early and later stages in two treatment modalities. A summary.
    Moise R; Reed BG; Conell C
    Int J Addict; 1981 Oct; 16(7):1295-300. PubMed ID: 7327794
    [No Abstract]   [Full Text] [Related]  

  • 43. Rational choice and environmental deterrence in the retention of mandated drug abuse treatment clients.
    Sung HE; Richter L
    Int J Offender Ther Comp Criminol; 2007 Dec; 51(6):686-702. PubMed ID: 17615436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follow-up contact bias in adolescent substance abuse treatment outcome research.
    Stinchfield RD; Niforopulos L; Feder SH
    J Stud Alcohol; 1994 May; 55(3):285-9. PubMed ID: 8022175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence.
    Paraherakis A; Charney DA; Palacios-Boix J; Gill K
    Can J Psychiatry; 2000 Dec; 45(10):927-31. PubMed ID: 11190363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Program monitoring for clinical practice. Specimen positivity across urine collection methods.
    Moran J; Mayberry C; Kinniburgh D; James D
    J Subst Abuse Treat; 1995; 12(3):223-6. PubMed ID: 7474030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of female addicts: the importance of relationships to parents, partners, and peers for the outcome.
    Ravndal E; Vaglum P
    Int J Addict; 1994 Jan; 29(1):115-25. PubMed ID: 8144265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of centralized intake on outcomes of substance abuse treatment.
    Rohrer JE; Vaughan MS; Cadoret RJ; Carswell C; Patterson A; Zwick J
    Psychiatr Serv; 1996 Nov; 47(11):1233-8. PubMed ID: 8916242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic strategies with drugs].
    Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):1-2. PubMed ID: 8146237
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug treatment process indicators for probationers and prediction of recidivism.
    Broome KM; Knight K; Hiller ML; Simpson DD
    J Subst Abuse Treat; 1996; 13(6):487-91. PubMed ID: 9219146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should tolerance and withdrawal be required for substance dependence disorders?
    Carroll KM; Rounsaville BJ; Bryant KJ
    Drug Alcohol Depend; 1994 Aug; 36(1):15-22. PubMed ID: 7988354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Following the pioneers. Addressing tobacco in chemical dependency treatment.
    Hoffman AL; Slade J
    J Subst Abuse Treat; 1993; 10(2):153-60. PubMed ID: 8389896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Initial Evaluation of a Comprehensive Continuing Care Intervention for Clients with Substance Use Disorders: My First Year of Recovery (MyFYR).
    McKay JR; Knepper C; Deneke E; O'Reilly C; DuPont RL
    J Subst Abuse Treat; 2016 Aug; 67():50-4. PubMed ID: 27296662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substance abuse treatment outcomes among American Indians in the Telephone Aftercare Project.
    Chong J; Herman-Stahl M
    J Psychoactive Drugs; 2003; 35(1):71-7. PubMed ID: 12733761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug misuse treatment services in Scotland: predicting outcomes.
    Morris ZS; Gannon M
    Int J Qual Health Care; 2008 Aug; 20(4):271-6. PubMed ID: 18492708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comprehensive review: methodological rigor of studies on residential treatment centers for substance-abusing adolescents.
    Tripodi SJ
    J Evid Based Soc Work; 2009 Jul; 6(3):288-99. PubMed ID: 20183679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.